Bio-Equity 2025

We are pleased to announce that Sebastien Stoitzner will be attending BioEquity in Bruges 12-14 May. As a key figure in our organisation’s commitment to growth and innovation within the Life Sciences sector, Sebastien’s presence at this renowned conference underlines our dedication to staying at the forefront of industry developments.
Read more “Bio-Equity 2025”

Exploring the Future of Cell and Gene Therapies at Our HealthTech Leadership Dinner in Basel

We had the pleasure of co-hosting our #HealthTech Dinner in Basel with our partners at PwC Switzerland—an evening dedicated to exploring the evolving future of cell and gene therapies.

A heartfelt thank you to our guest speakers, Joshi Venugopal (Novartis Gene Therapies & Rare Diseases) and Gunther Busam (Orchard Therapeutics – U.S.), for their thought-provoking contributions.

Read more “Exploring the Future of Cell and Gene Therapies at Our HealthTech Leadership Dinner in Basel”

Sébastien Stoitzner & Thibault Vercoutere Attend the Health Innovation Agency’s CAP Tour – Marseille

GenSearch Signs the French Charte de la Diversité

Formalising Our Commitment to Workplace Inclusion in Executive Search

Supporting Diversity in Life Sciences Recruitment

GenSearch has signed the Charte de la Diversité, a national charter in France that encourages organisations to take practical action against discrimination and promote inclusion across all areas of employment. This commitment reflects our intention to build fairer recruitment processes and contribute to more representative leadership in the life sciences sector.

Charte-de-la-diversite

What Is the Charte de la Diversité?

Launched in 2004, the Charte de la Diversité brings together organisations that voluntarily commit to advancing diversity in the workplace. Signatories work to ensure:

  • Awareness and training on diversity and inclusion
  • Equal opportunities during recruitment and career progression
  • Representation of societal diversity within their teams
  • Transparent evaluation and accountability mechanisms

Over 5,000 companies in France have signed the Charter to date, spanning a wide range of industries and sectors.

Why This Matters for Executive Search

In executive search for the life sciences industry, inclusive hiring is essential. Signing the Charte de la Diversité strengthens GenSearch’s alignment with best practices in:

  • Fair and unbiased recruitment: Ensuring all candidates are evaluated on skills, experience, and potential — not personal background
  • Inclusive leadership advisory: Helping clients build diverse executive teams that reflect their markets and stakeholders
  • Internal workplace equity: Promoting respect, safety, and opportunity within our own teams

Diversity in leadership leads to more robust decision-making, increased innovation, and stronger organisational performance — all critical factors in healthcare and science.

HealthTech Dinner – Basel

Heiko Bruhn
 Sule Erdim Ersoy from Novo Nordisk and Hans-Juergen Woerle Nestle

At the HealthTech Dinner last week, hosted by GenSearch and PwC Switzerland and, we gathered to explore one of today’s most impactful topics in healthcare: Transforming the future of obesity care.

The evening brought together brilliant minds in Pharma and Life Sciences, with insights shared by Sule Erdim Ersoy from Novo Nordisk and Hans-Juergen Woerle from Nestlé Health Science.

Read more “HealthTech Dinner – Basel”